Prevalence and severity of substance use disorders and onset of psychosis in first-admission psychotic patients

Psychological Medicine

Volumn 28, Issue 6, 1998, Pages 1411-1419

  Rabinowitz, J ^a,b   Bromet, E J ^a   Lavelle, J ^a   Carlson, G ^a   Kovasznay, B ^a   Schwartz, J E ^a  

^a STONY BROOK UNIVERSITY   (United States)

^b BAR ILAN UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ANTISOCIAL BEHAVIOR; ARTICLE; CHILDHOOD; CIGARETTE SMOKING; DISEASE SEVERITY; FEMALE; GENDER; HOSPITAL ADMISSION; HUMAN; LIFESPAN; MAJOR CLINICAL STUDY; MALE; MENTAL PATIENT; ONSET AGE; PERSONALITY; PSYCHOSIS; REMISSION; SOCIOLOGY; SUBSTANCE ABUSE; SYMPTOMATOLOGY; THOUGHT DISORDER;

ADOLESCENT; ADULT; ANTISOCIAL PERSONALITY DISORDER; BIPOLAR DISORDER; COMORBIDITY; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; MALE; MIDDLE AGED; NEW YORK CITY; PATIENT ADMISSION; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTIC DISORDERS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SUBSTANCE-RELATED DISORDERS;

EID: 0031774802     PISSN: 00332917     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0033291798007399     Document Type: Article

References (45)

1. Ammons, R. B. & Ammons, C. H. (1962). The Quick Test: provisional manual. Psychological Reports 11, 111-161.
2. Andreasen, N. C. (1981). The Scale for the Assessment of Negative Symptoms (SANS). University of Iowa : Iowa City, Iowa.
3. Andreasen, N. C. (1984). The Scale for the Assessment of Positive Symptoms (SAPS). The University of Iowa: Iowa City.
4. Andreasson, S., Allebeck, P. & Rydberg, U. (1989). Schizophrenia in users and nonusers of cannabis. Acta Psychiatrica Scandinavica 79, 505-510.
5. Arndt, S., Tyrrell, G., Flaum, M. & Andreasen, N. C. (1992). Comorbidity of substance abuse and schizophrenia: the role of pre-morbid adjustment. Psychological Medicine 22, 389-398.
6. Baigent, M., Holme, G. & Hafner, J. R. (1995). Self reports of the interaction between substance abuse and schizophrenia. Australian and New Zealand Journal of Psychiatry 29, 69-74.
7. Barbee, J. G., Clarke, P. D., Crapanzano, M. S., Heintz, G. C. & Kehoe, C. E. (1989). Alcohol and substance abuse among schizophrenic patients presenting to an emergency psychiatric service. Journal of Nervous and Mental Disease 177, 400-407.
8. Berkson, J. (1946). Limitations of the application of fourfold table analysis to hospital data. Biometrics 2, 47-53.
9. Bowers, M. B., Mazure, C. M., Nelson, J. C. & Jatlow, P. I. (1990). Psychotogenic drug use and neuroleptic response. Schizophrenia Bulletin 16, 81-85.
10. Brady, K., Anton, R., Ballenger, J. C., Lydiard, R. B., Adinoff, B. & Selander, J. (1990). Cocaine abuse among schizophrenic patients. American Journal of Psychiatry 147, 1164-1167.
11. Breakey, W. R., Goodell, H., Lorenz, P. C. & McHugh, P. R. (1974). Hallucinogenic drugs as precipitants of schizophrenia. Psychological Medicine 4, 255-261.
12. Bromet, E. J., Schwartz, J. E., Fennig, S., Geller, L., Jandorf, L., Kovasznay, B., Lavelle, J., Miller, A., Pato, C., Ram, R. & Rich, C. (1992). The epidemiology of psychosis: the Suffolk County Mental Health Project. Schizophrenia Bulletin 18, 243-255.
13. Bromet, E. J., Dew, M. A. & Eaton, W. (1995). Epidemiology of Psychosis with Special Reference to Schizophrenia. In Textbook in Psychiatric Epidemiology (ed. M. T. Tsuang, M. Tohen and J. Zahner), pp. 283-300. John Wiley & Sons: New York.
14. Bromet, E. J., Jandorf, L., Fennig, S., Lavelle, J., Kovasznay, B., Ram, R., Tanenberg-Karant, M. & Craig, T. (1996). The Suffolk County Mental Health Project: demographic, pre-morbid and clinical correlates of 6-month outcome. Psychological Medicine 26, 953-962.
15. Cannon-Spoor, H., Potkin, G. & Wyatt, J. (1982). Measurement of premorbid adjustment in chronic schizophrenia. Schizophrenia Bulletin 8, 470-484.
16. Cleghorn, J. M., Kaplan, R., Szechtman, B., Szechtman, H., Brown, G. M. & Franco, S. (1991). Substance abuse and schizophrenia: effect on symptoms but not on neuro-cognitive functioning function. Journal of Clinical Psychiatry 52, 26-30.
17. Craig. A. R., Franklin, J. A. & Andrews, G. (1984). A scale to measure locus of control behaviour. British Journal of Medical Psychology 57, 173-180.
18. DeQuardo, J. R., Carpenter. C. F. & Tandon, R. (1994). Patterns of substance abuse in schizophrenia : nature and significance. Journal of Psychiatric Research 28, 267-275.
19. Dixon, L., Haas, G., Weiden, P. J., Sweeney, J. & Frances, A. J. (1991). Drug abuse in schizophrenic patients: clinical correlates and reasons for use. American Journal of Psychiatry 148, 224-230.
20. Drake, R. E., Osher, F. C. & Wallach. M. A. (1989). Alcohol use and abuse in schizophrenia : a prospective community study. Journal of Nervous and Mental Disease 177, 408-414.
21. Folstein, M., Folstein, A. & McHugh, P. (1975). Mini-mental state: a practical method for grading cognitive state of patients for the clinician. Journal of Psychiatric Research 12, 189-198.
22. Guy, W. (ed.) (1976). ECDEU Assessment Manual for Psychopharmacology (Revised edn). US Department of Health Education and Welfare: Washington, DC.
23. Kendler, K. S., Lieberman, J. & Walsh, D. (1989). The Structural Interview for Schizotypy (SIS) : a preliminary report. Schizophrenia Bulletin 15, 559-591.
24. Kendler, K. S., Gallagher, T. J., Abelson, J. M. & Kessler, R. (1996). Lifetime prevalence, demographic risk factors, and diagnostic validity of nonaffective psychosis as assessed in a US community sample. Archives of General Psychiatry 53, 1022-1031.
25. Kessler, R. C. McGonagle, K. A., Zhao, S., Nelson, C. B., Hughes, M., Eshleman, S., Wittchen, H.-U. & Kendler, K. S. (1994). Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Archives of General Psychiatry 51, 8-19.
26. Kovasznay, B. (1991). Substance abuse among veterans with a diagnosis of schizophrenia. Hospital and Community Psychiatry 42, 948-949.
27. Kovasznay, B., Bromet, E., Schwartz, J. E., Ram, R., Lavelle, J. & Brandon. L. (1993). Substance abuse and onset of psychotic illness. Hospital and Community Psychiatry 44, 567-571.
28. Linszen, D. H., Dingemans, P. M. & Lenior, M. E. (1994). Cannabis abuse and the course of recent-onset schizophrenic disorders. Archives of General Psychiatry 51, 273-279.
29. Lysaker, P., Bell, M., Beam-Goulet, J. & Milstein, R. (1994). Relationship of positive and negative symptoms to cocaine abuse in schizophrenia. Journal of Nervous and Mental Disease 182, 109-112.
30. Mueser, K. T., Yarnold, P. R., Levinson, D. F., Singh, H., Bellack, A. S., Kee, K., Morrison, R. L, & Yadalam, K. G. (1990). Prevalence of substance abuse in schizophrenia : demographic and clinical correlates. Schizophrenia Bulletin 16, 31-56.
31. National Institute on Drug Abuse (1988). National Household Survey on Drug Abuse: Main Findings 1985 (DHHS Publication No. (ADM) 88-1586). US Government Printing Office: Washington, DC.
32. Overall, J. E. & Gorham, D. E. (1961). The Brief Psychiatric Rating Scale. Psychological Reports 10, 799-812.
33. Peralta, V. & Cuesta, M. J. (1992). Influence of cannabis abuse on schizophrenic psychopathology. Acta Psychiatrica Scandinavica 85, 127-130.
34. Pulver, A. E., Wolyniec, P. S., Wagner, M. G., Moorman, C. C. & McGrath, J. A. (1989). An epidemiologic investigation of alcohol-dependent schizophrenics. Acta Psychiatrica Scandinavica 79, 603-612.
35. Seibyl, J. P., Satel, S. L., Anthony, D., Southwick, S. M., Krystal. J. H. & Charney, D. S. (1993). Effects of cocaine on hospital course in schizophrenia. Journal of Nervous and Mental Disease 181, 31-37.
36. Serper, M. R., Alpert, M., Richardson, N. A., Dickson, S., Allen, M. H. & Werner, A. (1995). Clinical effects of recent cocaine use on patients with acute schizophrenia. American Journal of Psychiatry 152, 1464-1469.
37. Sevy, S., Kay, S. R., Opler, L. A. & Van Praag, H. M. (1990). Significance of cocaine history in schizophrenia. Journal of Nervous and Mental Disease 178, 642-648.
38. Siris, S. G., Kane, J. M., Frechen, K., Sellew, A. P., Mandeli, J. & Fasano-Dube, B. (1988). Histories of substance abuse in patients with postpsychotic depressions. Comprehensive Psychiatry 29, 550-557.
39. Spitzer, R. L., Williams, J. B. W., Gibbon, M. & First, M. B. (1992). The Structured Clinical Interview for DSM-III-R (SCID). I: History, rationale, and description. Archives of General Psychiatry 49, 624-629.
40. Strakowski, S. M., Keck, P. E., McElroy, S. L., Lonczak, H. S. & West, S. A. (1995). Chronology of comorbid and principal syndromes in first-episode psychosis. Comprehensive Psychiatry 36, 106-112.
41. Strauss, J. S. & Carpenter. W. T. (1974), The prediction of outcome in schizophrenia. Archives of General Psychiatry 31, 37-42.
42. Swofford, C. D., Kasckow, J. W., Scheller-Gilkey, G. & Inderbitzin, L. B. (1996). Substance use: a powerful predictor of relapse in schizophrenia. Schizophrenia Research 20, 145-151.
43. Tsuang, M. T., Simpson, J. C. & Kronfol, Z. (1983). Subtypes of drug abuse with psychosis: Demographic characteristics, clinical features and family history. Archives of General Psychiatry 39, 141-147.
44. Woerner, M., Manuzza, S. & Kane, J. (1988). Anchoring the BPRS: an aid to improved reliability. Psychopharmacology Bulletin 24, 112-124.
45. Zisook, S., Heaton, R., Moranville, J., Kuck, J., Jernigan, T. & Braff, D. (1992). Past substance abuse and clinical course in schizophrenia. American Journal of Psychiatry 149, 552-553.